Directorate Change

Tate & Lyle PLC 5 April 2005 - Tate & Lyle PLC TATE & LYLE BOARD CHANGE Tate & Lyle PLC announces today that Dr. Barry L. Zoumas has been appointed as a Non-Executive Director with effect from 1 May 2005. Dr. Zoumas, aged 62, is the Alan R. Warehime Professor of Agribusiness and Professor of Food Science and Nutrition at The Pennsylvania State University. In addition, he is President of the International Life Sciences Institute, North American Branch, of which he is also a Director. He is based in the USA. Dr. Zoumas worked for Hershey Foods Corporation for 27 years, the last sixteen as Corporate Vice President, Science and Technology with responsibility for R&D, Corporate Engineering, Quality Assurance, Agribusiness and Regulatory Affairs. He has extensive international experience having previously served as Visiting Scientist for the Rome-based Food and Agriculture Organization of the United Nations and as a Principal Advisor to US Aid for Agricultural Development. He sits on a wide range of major committees and associations impacting the food business, holds a number of important scientific awards and has a range of publications and US patents to his name. Sir David Lees, Chairman of Tate & Lyle, said 'I am delighted that Dr. Zoumas is to join the Board as a Non-Executive Director. His background as a scientist and businessman will add diversity and strength to the Board and offer an important perspective on our business development.' CONTACTS Chris Fox, Director of Corporate Relations (Press) Tel: 020 7626 6525 or Mobile: 07801 808553 Mark Robinson, Head of Investor Relations Tel: 020 7626 6525 or Mobile: 07793 515861 investorrelations@tateandlyle.com Tate & Lyle is a world leading manufacturer of renewable food and industrial ingredients. It uses innovative technology to transform corn, wheat and sugar into value-added ingredients for customers in the food, beverage, pharmaceutical, cosmetic, paper, packaging and building industries. The Company is a leader in cereal sweeteners and starches, sugar refining, value added food and industrial ingredients, and citric acid. Tate & Lyle is the world number-one in industrial starches and is the sole manufacturer of SPLENDA® Sucralose. Headquartered in London, Tate & Lyle is listed on the London Stock Exchange under the symbol TATE.L. In the US its ADRs trade under TATYY. The Company operates more than 60 production facilities in 28 countries, throughout Europe, the Americas and South East Asia. It employs 6,700 people in its subsidiaries with a further 4,800 employed in joint ventures. Sales in the year to 31 March 2004 totalled £3.1 billion. Additional information can be found on www.tateandlyle.com. SPLENDA® is a trademark of McNeil Nutritionals¸ LLC

Companies

Tate & Lyle (TATE)
UK 100

Latest directors dealings